# FDA Inspection 1322326 - TriRx Huntsville Pharmaceutical Services, LLC - June 15, 2026

Source: https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/84548e82-46e0-4e70-b7ac-63ce50cfbc7f
Source feed: FDA_Inspections

> FDA Inspection 1322326 for TriRx Huntsville Pharmaceutical Services, LLC on June 15, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1322326
- Company Name: TriRx Huntsville Pharmaceutical Services, LLC
- Inspection Date: 2026-06-15
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: New Orleans District Office

## Related Documents

- [FDA Inspection 1216782 - 2023-08-11](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/3b33daf8-bfa6-437e-9d8f-1611b733a98f)
- [FDA Inspection 1166895 - 2022-04-01](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/3f8dc216-6d17-4b5b-a74a-14052c6e9579)
- [FDA Inspection 978625 - 2016-04-21](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/89ab6faa-5411-4e35-966a-c29e63d3031b)
- [FDA Inspection 908381 - 2014-12-19](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/0fc0cd41-2f65-4177-ad00-19793dfbefed)
- [FDA Inspection 891076 - 2014-08-01](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/2d1caa8e-ca78-44d1-9156-75f72a2a356a)

Company: https://www.keypedia.com/companies/trirx-huntsville-pharmaceutical-services-llc/bdf3220b-2a57-4125-b4ef-af4d1d9c9fa8

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea